Immediate Impact
34 standout
Citing Papers
Aptamers as an approach to targeted cancer therapy
2024 Standout
Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study
2022 Standout
Works of M. Benchalal being referenced
Phase II study of concomitant radiotherapy with atezolizumab in oligometastatic soft tissue sarcomas: STEREOSARC trial protocol
2020
R-CHOP with or without Radiotherapy in Non-Bulky Limited-Stage Diffuse Large B Cell Lymphoma (DLBCL): Preliminary Results of the Prospective Randomized Phase III 02-03 Trial from the Lysa/Goelams Group
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| M. Benchalal | 90 | 27 | 63 | 70 | 19 | 168 | |
| Anne Hong | 94 | 48 | 121 | 59 | 22 | 254 | |
| Sidney M. Silverstone | 70 | 11 | 41 | 95 | 22 | 218 | |
| B. Dessard-Diana | 88 | 23 | 94 | 139 | 19 | 290 | |
| Stefania Martini | 73 | 24 | 111 | 61 | 20 | 269 | |
| Shashikant Juvekar | 97 | 17 | 96 | 123 | 22 | 247 | |
| Camilla Delli Paoli | 134 | 36 | 109 | 42 | 22 | 277 | |
| Francesco Martucci | 87 | 26 | 127 | 75 | 25 | 225 | |
| S. Andrew Peng | 181 | 18 | 136 | 32 | 16 | 272 | |
| Won Taek Kim | 64 | 50 | 84 | 81 | 19 | 268 | |
| Michel Rives | 106 | 8 | 66 | 88 | 17 | 239 |
All Works
Loading papers...